Gevo, Inc. — Director's Dealing 2013

Dec 18, 2013

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Gevo, Inc. (GEVO)
CIK: 0001392380
Period of Report: 2013-12-16

Reporting Person: KISHORE GANESH (Director)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2013-12-16	Common Stock	P	37037	—	Acquired	89295	Direct
2013-12-16	Common Stock	P	370370	—	Acquired	2041795	Indirect

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2013-12-16	Common Stock Warrant (right to buy)	$1.85	P	37037	Acquired	2018-12-16	Common Stock (37037)	Direct
2013-12-16	Common Stock Warrant (right-to-buy)	$1.85	P	370370	Acquired	2018-12-16	Common Stock (370370)	Indirect

Footnotes

F1: The shares of common stock and the warrants to purchase common stock were purchased together as common stock units, but were issued separately. Each common stock unit consisted of one share of common stock and a warrant to purchase one share of common stock, at a public offering price of $1.35 per common stock unit. Each warrant has an exercise price of $1.85 per share (subject to adjustment in certain circumstances), became exercisable on the date of original issuance and will expire on December 16, 2018.

F2: The reporting person is deemed to be the beneficial owner of shares held by Malaysian Life Sciences Capital Fund Ltd. as previously reported on the Form 4 filed February 15, 2011.